Clinical Trial Update: Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

This clinical trial update confirms the completion of a Phase 2 study evaluating perhexiline for hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED